Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
New Anti-GHSR Antibodies from AnaSpec
AnaSpec has announced the release of two antibodies for growth secretagogue receptor (GHSR). One antibody targets the N-terminus and the other an internal sequence. GHSR is a G protein-coupled receptor with seven transmembrane domains and is primarily expressed in hypothalamus and pituitary glands... - August 30, 2008 - AnaSpec, EGT Group
AnaSpec and UW TechTransfer Sign Licensing Agreement for Protein Tyrosine Phosphatases
AnaSpec and UW TechTransfer today announced a licensing agreement that will allow AnaSpec to make, use, and sell Protein Tyrosine Phosphatase Substrates as covered by UW’s patent # 5,739,278 entitled “Compositions for Protein Tyrosine Phosphatases.” "We are pleased to... - August 29, 2008 - AnaSpec, EGT Group
Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17)
Dr. Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono International in Geneva, Switzerland will present at the Plenary Keynote session at GTCbio’s 4th Modern Drug Discovery and Development Summit on October 15-17, 2008 at the Hilton La Jolla Torrey Pines in La Jolla,... - August 23, 2008 - GTCbio
Stanley Deresinski, Clinical Professor of Medicine-Med/Infectious Diseases, Stanford University to Give Featured Presentation at GTCbio’s Bugs & Drugs Conf. on Sep 22-23
Dr. Stanley Deresinski, Clinical Professor of Medicine-Med/Infectious Diseases at Stanford University in Palo Alto, CA will speak on “The Seemingly Never-ending Promise of Bacteriophage Therapy: Exploiting Smaller Fleas” at GTCbio’s Bugs & Drug Conf. on Sept. 22-23, 2008 at... - August 21, 2008 - GTCbio
Sharath Hegde, Vice President at Theravance to Give Featured Presentation at GTCbio’s Bugs & Drugs Conference on September 22-23, 2008 in San Diego, CA
Sharath Hegde, Vice President of Pharmacology at Theravance, Inc. in South San Francisco, CA will speak on “Telavancin: A Novel Lipoglycopeptide Gram-Positive Antibiotic” at GTCbio’s Bugs & Drug Conference on September 22-23, 2008 at the DoubleTree Club Hotel in San Diego,... - August 21, 2008 - GTCbio
Rita Helfand, Associate Director at the Centers for Disease Control and Prevention (CDC) to Give Featured Presentation at GTCbio’s Bugs & Drugs Conference on Sept. 22-23
Dr. Rita Helfand, Associate Director of Epidemiologic Science at the National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention will speak on “Controlling Infectious Diseases: Progress and Challenges in Addressing Known and... - August 21, 2008 - GTCbio
Barry Eisenstein, SVP at Cubist Pharmaceuticals to Give Keynote Presentation at GTCbio’s Bugs & Drugs Conference on September 22-23, 2008 in San Diego, CA
Dr. Barry Eisenstein, Senior Vice President of Scientific Affairs at Cubist Pharmaceuticals in Lexington, MA and Clinical Professor of Medicine, Harvard Medical School in Cambridge, MA gives the keynote address on getting congress to understand the need for antibiotic development. In contrast to... - August 21, 2008 - GTCbio
Biocore and AnaSpec Sign Distributor Agreement
AnaSpec and Biocore Pty Ltd today announced a non-exclusive distributor agreement that will allow Biocore Pty Ltd to distribute AnaSpec’s catalog and custom products throughout Australia. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec is pleased... - August 14, 2008 - AnaSpec, EGT Group
AnaSpec Introduces GO Peptides™ - Research-Ready Peptides on Demand
AnaSpec is pleased to introduce GO Peptides™, the next evolution in peptide tools. - August 13, 2008 - AnaSpec, EGT Group
VP of Alliance Management & Portfolio Planning at Genentech to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit Oct. 15-17, '08 – San Diego
Dr. Ashraf Hanna, Vice President of Alliance Management and Portfolio Planning at Genentech in San Francisco, CA will present at the Plenary Keynote session at GTCbio’s 4th Modern Drug Discovery and Development Summit on October 15-17, 2008 in La Jolla, CA. Dr. Hanna will present on The Cost... - August 09, 2008 - GTCbio
GTCbio Announces Its Annual Conference Global Clinical Trial Operations on September 25-26, 2008, San Diego, CA
GTCbio just announced the commencement of its inaugural conference on Global Clinical Trial Operations taking place on September 25-26, 2008 in San Diego, CA. Outsourcing to CROs has proven to be much more cost effective and less time consuming when conducting clinical trials. The steps to... - August 09, 2008 - GTCbio
GTCbio Announces Its Biomarker Discovery Europe Conference on October 2-3, 2008 in Dublin, Ireland
GTCbio just announced the 3rd edition of its Biomarker Series – the Biomarker Discovery Europe Conference - taking place on October 2-3, 2008 in Dublin, Ireland. Over the last several years, biomarkers have been an increasingly important and a heavily researched topic at all of the leading... - August 09, 2008 - GTCbio
GTCbio Announces Its 4th Annual Neurodegenerative Diseases Drug Discovery Conference on October 9-10, 2008 in Philadelphia, Pa
GTCbio just announced the scheduling of its 4th annual Neurodegenerative Diseases Drug Discovery Conference on October 9-10, 2008 in Philadelphia, PA. Neurodegenerative diseases continue to play an enormous role in the growing public health problem, disrupting the quality of life of millions of... - August 09, 2008 - GTCbio
GTCbio Announces Its Inaugural Bugs & Drugs Conference on September 22-23, 2008, San Diego, CA
GTCbio just announced its inaugural Bugs & Drugs conference – one of the leading forums to address unmet medical needs for problematic microbials - taking place on September 22-23, 2008 in San Diego, CA. Infections are becoming increasingly problematic due to the recent resistances to... - August 09, 2008 - GTCbio
AnaSpec Introduces New SensoLyte™ 570 Generic MMP Assay Kit with Industry’s Highest Wavelength
Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated proteins capable of digesting extracellular matrix components. The importance of MMPs in tumor development and invasion as well as other diseases is well known. AnaSpec has introduced the SensoLyteTM 570 Generic... - August 09, 2008 - AnaSpec, EGT Group
Indian Biotech Market Gaining Traction from Biopharma
Biopharma has made a strong foothold in the Indian biotech market and added 70% of the total revenue alone in 2007-08, says new report from RNCOS. - August 06, 2008 - RNCOS
Novus Biologicals and AnaSpec Sign Licensing Agreement for HiLyte™ Dyes
AnaSpec and Novus Biologicals today announced a licensing agreement that will allow Novus Biologicals to label Novus antibodies with AnaSpec HiLytePlus™ and HiLyte Fluor™ dyes. HiLytePlus™ and HiLyte Fluor™ are AnaSpec's proprietary series of high performance fluorescent... - July 30, 2008 - AnaSpec, EGT Group
AnaSpec Offers Custom Peptide-Aminoluciferin Synthesis
AnaSpec now offers custom synthesis service of peptide-aminoluciferin substrates. - July 23, 2008 - AnaSpec, EGT Group
End Malaria – Blue Ribbon Campaign, Welcomed at European Meeting
Dr. Mary Galinski, Founder and President of the Malaria Foundation International, attended the International Conference on Malaria held April 21-22 in Bonn, Germany: Joining Forces, Synergizing Action, Sustainable and innovative ways of ensuring long-term prevention and treatment measures by 2015. The MFI's End Malaria - Blue Ribbon pins were welcomed at the meeting. - July 22, 2008 - Malaria Foundation International
Robert Davie, VP at Covance to Present at GTCbio’s Global Clinical Trial Operations Conference on September 25-26, 2008 in San Diego, CA
Dr. Robert J. Davie, Vice President & General Manager of Clinical Development Services - Europe at Covance will give a presentation entitled “The Service Provider Perspective: How are CROs Preparing for the Future of Clinical Outsourcing?” at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. - July 18, 2008 - GTCbio
Colorado BioScience Association Launches New Pilot Externship Program, Connecting Jefferson County High School Science Teacher with Boulder's Array BioPharma
Colorado BioScience Association (CBSA) has announced the debut of a new educational program this summer – an externship for a local high school science teacher at one of the area’s prominent biotechnology companies. Tamra Miaja, a Bear Creek High School biology teacher is the first teacher to take part in CBSA’s pilot externship program and has spent part of her summer at Array BioPharma, headquartered in Boulder. - July 17, 2008 - Colorado BioScience Association
Korea's Largest Biotech Show Kicks Off in Osong
The 3rd BIO KOREA convention will be held from October 8th to 10th at Osong Bio-Technopolis. The event of this year offers a variety of high-level conference, international exhibition and partnership events and provide an opportunity to find business and technology partners. It expects to 350 companies and 25,000 visitors from all over the world. - July 17, 2008 - Bio Korea
Anavex Life Sciences Corp. Will Present New Findings at the International Conference on Alzheimer's Disease 2008 (July 26-31, 2008, Chicago, USA)
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) announces its participation at the International Conference on Alzheimer's Disease 2008 (July 26-31, 2008, Chicago, USA), where it will present results obtained with Anavex 1-41 demonstrating a protective effect against the neurotoxicity... - July 15, 2008 - Anavex Life Sciences Corp.
Pure Power Unveils Commercial Energy Farming Opportunities
Versatile willow crops provide biofuel feedstock and remediate marginal land. - July 11, 2008 - Pure Power
AnaSpec Introduces New Series of PAR Peptides
AnaSpec has introduced its latest series of PAR peptides. - July 09, 2008 - AnaSpec, EGT Group
New Anti-Keratin Antibodies Introduced by AnaSpec
AnaSpec has introduced two keratin antibodies that recognize both the intact and caspase digested N-terminal of K18 and K19 at Asp237. These antibodies are useful tools for studying keratin dynamics in mice undergoing hepatocyte apoptosis, patients with cirrhosis, and also in apoptotic cells of... - July 04, 2008 - AnaSpec, EGT Group
M-Scan Ltd Successfully Passes GMP Inspections by the FDA and UK MHRA
The world-leading provider of contract analytical services now conducts bio/pharmaceutical analysis to both GMP and GLP (compliant since 1992.) - July 04, 2008 - M-Scan
Colorado Confirmed as Top Bioscience State by National Rankings
It’s been a banner year for Colorado in the highly competitive state rankings arena. Genome Technology’s June publication ranks Colorado as one of the top 20 biotech locations in the world, and the Families USA Global Health Initiative Report ranked Colorado fourth among states that generated the most economic activity per dollar of funding from the NIH. Further, Colorado placed in the top five of all five categories in the Milken Institute’s State Technology and Science Index. - July 02, 2008 - Colorado BioScience Association
New SensoLyte HDAC Assay Kit Introduced by AnaSpec
Histone deacetylase (HDAC) enzymes modulate gene expression through the deacetylation of lysine residues on histone proteins and act as transcriptional repressors of genes. Based on their role in cell cycling, apoptosis and differentiation, HDACs have been chosen as therapeutic targets for the... - June 27, 2008 - AnaSpec, EGT Group
Beacon Software Picks ePayment Consultants (ePC) as Best Service Provider Using Their Web-Enabled Suite of Modular Applications
"With the Beacon System, we can monitor quality and timeliness metrics, interface with Customers through the Internet and ultimately predict Customer satisfaction with all of our services." --- Paul Nee, CEO ePayment Consultants - June 20, 2008 - ePayment Consultants.com
Cosimo Spera from Decision View Co. speaking at GTCbio’s Global Clinical Trial Operations Conference
Cosimo Spera from Decision View Co. will give a presentation entitled “Marrying Complex Mathematical Models with Highly Usable Software Solutions to Improve Trial Enrollment Performance” at GTCbio’s Global Clinical Trial Operations Conference. - June 20, 2008 - GTCbio
Charlene Dark from Clarkston Consulting to Speak at GTCBio’s Global Clinical Trial Operations Conference
Charlene Dark, Dir. of Life Sciences at Clarkston Consulting will be present on expediting accuracy through electronic data capture at GTCbio’s Global Clinical Trial Operations Conference on Sept. 25-26 in San Diego. - June 20, 2008 - GTCbio
Brahm Goldstein of Novo Nordisk to Speak at GTCbio’s Global Clinical Trial Operations Conference
Brahm Goldstein Novo Nordisk speaking regarding a rational approach towards pediatric drug development in the pharmaceutical industry at GTCbio’s Global Clinical Trial Operations Conference on 9/25-26. - June 20, 2008 - GTCbio
AnaSpec Offers Custom Synthesis of Hydrocarbon-Stapled Peptides
The innovative technique of hydrocarbon stapling in peptides is introducing valuable new functionality to peptide-related research. AnaSpec is pleased to offer custom synthesis for hydrocarbon-stapled peptides. Hydrocarbon-stapled peptides are peptides capable of forming stable alpha helical... - June 20, 2008 - AnaSpec, EGT Group
New Anti-CARMA Antibody Series Released by AnaSpec
AnaSpec has introduced a new series of IHC validated antibodies, Anti-CARMA/CARD/Bimp antibodies. CARMA proteins are scaffold molecules that belong to the membrane-associated guanylate kinase-like (MAGUK) and the caspase-associated recruitment domain (CARD) protein families. They play critical... - June 19, 2008 - AnaSpec, EGT Group
Amrit Ray, VP at BMS to Present at Global Clinical Trial Operations Conf. on Sept 25-26 in San Diego
Amrit Ray, Vice President of Bristol-Myers Squibb will give the keynote presentation at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. Dr. Ray will give a presentation entitled “The Next Generation of Pharmacovigilance - Clinical Trials and Drug Development in the New Era of Drug Safety. - June 18, 2008 - GTCbio
AnaSpec Introduces Eleven New Peptides
This week AnaSpec, a world leader in custom and catalog peptides, introduced eleven (11) new peptides. - June 18, 2008 - AnaSpec, EGT Group
Device Surpasses Steroids in Strength and Overall Athletic Performance Enhancement
A new episode of Super Human Radio® reveals real-life results in world ranked athletes using a new nighttime technique for improving strength, stamina, physical and mental performance while providing deep, recuperative sleep. - June 15, 2008 - EarthPulse Tech, LLC
Passport to Paternity: One Man Receives DNA Test, Long-Lost Daughter for Father's Day
In 1992, Michael Skipwith fathered a daughter while stationed at Subic Naval Base in the Philippines. He was transferred from the base one month before her birth and never heard from her mother again. Now, he has found her and has been petitioning for her U.S. citizenship, but one last step in the process--a DNA test--stood in the way. To celebrate Father's Day, DNA Diagnostics Center paid off Michael's DNA testing fees, just days before her immigration deadline was up. - June 13, 2008 - DNA Diagnostics Center
SVP and Site Head of Pfizer La Jolla to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 – San Diego, CA)
Dr. Keith James, Senior Vice President and Site Head of Pfizer La Jolla will present at the Plenary Keynote session at GTCbio’s 4th Modern Drug Discovery and Development Summit on October 15-17, 2008 at the Hilton La Jolla Torrey Pines in La Jolla, CA. Dr. James’ will speak on the... - June 12, 2008 - GTCbio
Chinese Drug Market Jumped 19% in 2007 to US$50 Bln - WiCON Launches China Pharmaceutical Guide 2008 (3rd Edition)
WiCON International Group, the publisher of Pharma China, announced the official publication of its China Pharmaceutical Guide 2008 (3rd Edition). According to latest estimates by WiCON in this annually-updated Guide, the size of the Chinese drug market (including all Western and traditional... - June 10, 2008 - WiCON International Group LLC
Genomic Nanosystems Announced Today That It Has Received the Exclusive Patent Rights for Clonal Amplification and Digital PCR (Polymerase Chain Reaction) from Cytonix
Genomic Nanosystems, LLC has received the exclusive patent rights to U.S. patent No. 6,143,496. Patent ‘496 was first to describe methods for detecting single nucleic acid molecules after one amplification step, for amplifying one or more nucleic acids in nano-scale volumes or regions, and for carrying out digital PCR. - June 01, 2008 - Genomic Nanosystems
New SensoLyte™ 520 Cathepsin S Assay Kit Introduced by AnaSpec
AnaSpec has introduced the SensoLyte™ 520 Cathepsin S Assay Kit to its broad collection of long wavelength FRET protease assay kits. - May 29, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Sixty New Peptides & 3 New Assay Kits
This week, AnaSpec introduced sixty (60) new catalog peptides and three (3) new assay kits. - May 27, 2008 - AnaSpec, EGT Group
Colorado Governor Bill Ritter to Attend 2008 BIO Conference and Expo, Marketing The State’s Bioscience Sector to 20,000 Industry Executives
Colorado Governor Bill Ritter will attend BIO 2008 in San Diego, California, June 18, 2008, marketing the State’s bioscience sector to more than 20,000 bioscience company executives, researchers, economic development agencies and service providers attending the four-day event. A Colorado Pavilion (Booth #3049), on the trade show floor, will feature the state’s research institutions and highlight Colorado’s support for bioscience companies and its business-friendly environment. - May 24, 2008 - Colorado BioScience Association
AnaSpec Introduces 8 New Antibody Products
AnaSpec added eight (8) new antibody products to its growing collection. - May 24, 2008 - AnaSpec, EGT Group
Author of Inner Paths to Outerspace, Slawek Wojtowicz, to be Guest on Paranormal Palace Radio
An investigation into experiences of other realms of existence and contact with otherworldly beings • Examines how contact with alien life-forms can be obtained through the “inner space” dimensions of our minds • Presents evidence that other worlds experienced through consciousness-altering technologies are often as real as those perceived with our five senses • Correlates science fiction’s imaginal realms with psychedelic research. - May 24, 2008 - Paranormal Palace
Trace Contaminant Detection by Ultraviolet Microscopy and Microspectroscopy
Detection and analysis of trace organic and inorganic contaminants on precision devices by ultraviolet microscopy and microspectroscopy. - May 23, 2008 - CRAIC Technologies, Inc.
The Scientist Magazine Uncovers How Procter & Gamble Uses Biology to Beat Dandruff
How biotechnology, carpet and scotch tape have helped to alleviate itchy scalps. - May 21, 2008 - The Scientist
AnaSpec Introduces ClearPoint™ Heavy Isotope-Labeled Peptides
AnaSpec has introduced ClearPoint™ Peptides, heavy isotope-labeled peptides for absolute quantitation (AQUA) of proteins. - May 18, 2008 - AnaSpec, EGT Group